PlainRecalls
FDA Drug Moderate Class II Terminated

Levetiracetam in 0.82% Sodium Chloride Injection, 500 mg per 100 mL (5 mg/mL), For Intravenous Infusion Only, Distributed By: AuroMedics Pharma LLC, E. Windsor, NJ 08520, NDC 55150-246-47.

Reported: May 9, 2018 Initiated: March 27, 2018 #D-0705-2018

Product Description

Levetiracetam in 0.82% Sodium Chloride Injection, 500 mg per 100 mL (5 mg/mL), For Intravenous Infusion Only, Distributed By: AuroMedics Pharma LLC, E. Windsor, NJ 08520, NDC 55150-246-47.

Reason for Recall

Lack of Assurance of Sterility; confirmed customer report of a leaking bags and mold found between the outer bag and the overwrap

Details

Recalling Firm
AuroMedics Pharma LLC
Units Affected
261250 bags
Distribution
US Nationwide
Location
East Windsor, NJ

Frequently Asked Questions

What product was recalled?
Levetiracetam in 0.82% Sodium Chloride Injection, 500 mg per 100 mL (5 mg/mL), For Intravenous Infusion Only, Distributed By: AuroMedics Pharma LLC, E. Windsor, NJ 08520, NDC 55150-246-47.. Recalled by AuroMedics Pharma LLC. Units affected: 261250 bags.
Why was this product recalled?
Lack of Assurance of Sterility; confirmed customer report of a leaking bags and mold found between the outer bag and the overwrap
Which agency issued this recall?
This recall was issued by the FDA Drug on May 9, 2018. Severity: Moderate. Recall number: D-0705-2018.